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ABSTRACT 
 
SANDRA ALTARAWNEH: Characterization of Salivary, Mucosal, and Denture Surfaces 
Role in Denture Stomatitis: an Exploratory Study  
(Under the direction of Sompop Bencharit D.D.S., M.S., Ph.D.) 
 
 
Objectives: To explore associations between clinical signs of stomatitis and tissue/denture 
infection, as well as salivary and serum biomarkers. Methods: An IRB approved, case-
control study enrolled 32 edentate subjects, 17 with healthy palatal mucosa as controls and 
15 with denture stomatitis (DS) (Newton‟s classification type II and III). Rate of salivary 
flow, exfoliative cytology, culture, salivary cytokines levels, serum C-reactive protein levels, 
and DNA-DNA checkerboard analyses were performed. Results: denture levels of yeast 
were higher and more strongly predictive of clinical DS than salivary or mucosal levels. 
Certain pro-inflammatory cytokines levels were increased in DS and associated with counts 
of C. albicans in saliva. Conclusions: the denture, rather than the inflamed palatal mucosa, is 
the primary C. albicans habitat. At this point, data suggest no evidence that DS can induce 
systemic inflammation. 
 
 
   
 
 
iii 
 
 
 
 
ACKNOWLEDGEMENTS 
 
 
In recognition of their time and effort in making this project possible, I would like to thank 
the members of my committee: Drs. Bencharit, Offenbacher, and Cooper, particularly Dr. 
Bencharit for his enthusiasm and support. I would also like to thank my parents, my brothers 
Tarek and Tamer, my Niece Zaina, and my best friend Abeer for always being there. 
 
 
 
 
 
 
 
 
 
 
iv 
 
 
 
 
 
 
TABLE OF CONTENTS 
 
I.   List of Figures …………………………………….……………………………………..   v 
II.  List of tables ……………………………………………………………………..….......  vi 
III. Introduction ………………………………………………………………………...…...   1 
IV. Chapter 1: Role of Candida Albicans in Saliva and on Mucosal and Denture 
                        Surfaces in Denture  Stomatitis………………...………………………..…..   3 
            A. Abstract …………………………………………………………………………..   4 
B. Introduction………………………………………………………………………   6 
C. Materials and methods……………………………………………………………...8 
D. Results…………………………………………………………………………..   16 
E. Discussion……………………………………………………………………….   20 
F. Conclusions..…………………………………………………………………….   24 
G. References……………………………………………………………………….  25 
V. Chapter 2: Levels of Salivary Cytokines and Candida albicans and Serum  
                      C-reactive protein in Denture Stomatitis…………………………….………..29 
 
A. Abstract…………………………………………………………………………  30 
 
B. Introduction……………………………………………………………………...  32 
C. Materials and methods………………………………………………………….... 
D. Results…………………………………………………………………………...  38 
E. Discussion………………………………………………………………………..  42 
F. Conclusions............................................................................................................  48 
G. References……………………………………………………………………………..   49 
VI. Conclusions…………………………………………………………………………….   54 
 
34
3 
8 
 
6 
25 
42 
 
 
v 
 
LIST OF FIGURES 
 
Figure 1-1. Clinical photographs of (A) a control subject, (B) Newton classification 
                    II stomatitis, and (C) Newton classification III stomatitis…………………  11 
Figure 1-2. PAS exfoliative cytology representative slides.(A) a healthy control 
                   benign smear, (B) DS fungal hyphae.............................................................  18 
 
Figure 2-1. A diagram showing the division of the palate area into quadrants for 
                   bacterial   biofilm collection from each of the 4 zones..……………….….….. 36 
 
Figure 2-2. A Scatter plot showing the relationship between two of the cytokines 
                    and the C.albicans count……….……………………………………….…   39 
 
Figure 2-3. A bar graph showing the C.albicans counts in saliva of DS and 
                   control   subjectts……………………….………………………………….   40 
 
 
 
 
 
vi 
 
LIST OF TABLES 
 
Table 1-1. Inclusion and Exclusion Criteria……………………………………………..     10 
Table 1-2. Xerostomia Questionnaire……………………………………………………     14 
Table 1-3. Demographics and baseline characteristics of the subjects…………………..     16 
Table 1-4. Flow rate of unstimulated and stimulated whole saliva ………………….…..    17 
Table 1-5. Exfoliative cytology results for palatal area, vestibular area and tongue…......   19 
Table 1-6. Prevalence of C.Albicans and Non-Albicans in Saliva, denture, and  
                  mucosal surfaces for control and DS subjects.……………………….……….    20 
 
Table 2-1. Salivary cytokines levels in control and DS groups…………………………..    38 
 
Table 2-2. Organisms detected with checkerboard DNA-DNA analysis of  
                  biofilm from denture surfaces.………………………………………………...    41 
 
Table 2-3. CRP levels in Control and DS groups…………………………………………   42 
 
 
 
 
 
  
 
 
Candida-associated denture stomatitis (CADS) is the most common form of oral candidal 
infection in denture wearers. CADS has a  multi-factorial etiology with both systemic and 
local factors being implied among the possible contributing factors such as nutritional 
deficiencies, malignancies, immune defects, dentures, commensal flora, and salivary factors. 
This multi-factorial etiology stems from the fact that no direct cause-effect relationship could 
be established with a specific factor/s, and this is clearly reflected in the various treatment 
regimens used for treatment from the use of antifungals, to antimicrobials, antiseptics, and 
relining or remaking the dentures. 
Candida species, especially the hyphal-forming C.albicans, Gram negative anaerobes, 
impaired salivary flow, and ill-fitting dentures have been investigated as possible causative 
factors in previous studies. The role of C.albicans has been controversial as for whether its 
presence in saliva, or denture (within the denture and denture biofilm), or in the mucosal 
tissue underneath the denture is the main reservoir for this microorganism as related to 
denture stomatitis (DS). Xerostomia has been implicated as a contributing factor in DS. One 
theory suggests that the absence of cleansing effect in case of xerostomia makes the host 
more susceptible for such opportunistic infections. However, different studies yielded 
different results in this regard and most of the studies were more concerned with the quantity 
rather than the quality of saliva (i.e saliva composition especially the salivary proteins and 
Introduction 
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their antimicrobial characteristics). DS is often associated with trauma from ill-fitting 
dentures that are associated with atrophic osseous ridge anatomy. It is unclear whether the 
inflammatory state of DS is inducing ridge resorption that results in a loose and easily 
displaced denture, or whether the trauma associated with the denture (e.g. through poor tissue 
adaption, clenching or inadequate inter-ridge space) can provide a mechanical stress that 
induces mucosal inflammation and bone resorption via poor tissue perfusion, necrosis or 
trauma. 
Although some progress has been made in revealing the mechanisms of epithelial and 
immunoregulatory interactions with Candida, there are major gaps in our knowledge 
regarding processes that lead to the establishment of candidiasis as an infection and the 
relationship between mucosal and systemic inflammatory responses. 
Considering the number of potential factors that are related to DS, an exploratory case-
control investigation was conducted aiming to examine the association between clinical signs 
of DS (measuring the severity of stomatitis with the Newton Score and the Denture fit using 
the Kapur index) and 1) the exfoliative cytology, 2) the microbial levels (bacteria and yeasts) 
present in saliva, on mucosal tissues and on denture surfaces, 3) the salivary flow rate and 
xerostomia symptoms, 4) and the level of inflammatory cytokines in saliva and systemic 
markers of inflammation that discriminate between DS and health.   
The goal was to elucidate the molecular mechanisms associated with denture stomatitis that 
could possibly lead to identification of potential biomarkers of the disease for monitoring 
therapy as well as gain insight in to pathogenesis to improve prevention and treatment.
  
 
Chapter 1 
 
 
Role of C. albicans in Saliva and on Mucosal and Denture Surfaces in Denture 
Stomatitis 
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Abstract 
Purpose: To explore the association between the levels of Candida in saliva, and on denture 
and mucosal surfaces of subjects with and without denture stomatitis (DS), as diagnosed 
clinically and characterized by exfoliative cytology.  Salivary flow rates were also examined 
as a possible disease modifier. 
Methods: An IRB approved, case-control study enrolled 32 edentate subjects. Seventeen 
subjects with no signs or symptoms of DS as controls and 15 with (DS) [Newton‟s 
classification type II (moderate) and III (severe)] were selected. Subjects completed a 
xerostomia questionnaire and salivary flow rates were measured.  Samples of unstimulated 
whole saliva (UWS) and stimulated whole saliva (SWS) were collected. UWS was used for 
fungal culturing, cytokine and proteomic analyses. Mucosal wetness was measured using 
sialopapers and periotron. Periodic acid Schiff (PAS) stain and quantitative exfoliative 
cytology was performed on samples from affected and unaffected mucosa from each subject. 
Levels of Candida species (albicans and non-albicans) were determined, expressed as 
colony-forming units, using salivary samples as well as swab samples obtained from 
denture‟s fitting surfaces, the affected and the unaffected mucosa. Biopsy samples were taken 
from the palate for whole transcriptome analyses by microarray. Cytokine, proteomic and 
transcriptomic analyses results are presented elsewhere.   
Results:  There were no significant differences in salivary flow rates, mucosal wetness or 
frequency of reported dry mouth comparing subjects with and without DS. Exfoliative 
cytology of mucosal smears demonstrated significantly higher (P=0.02) Inflammatory cells 
counts in DS subjects, as compared with healthy denture-wearers.  C. albicans counts were 
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significantly higher in saliva (P=0.03) and on denture surfaces (P=0.002) of DS subjects, 
whereas mucosal candidal counts and the presence of cytological hyphae did not show 
significant difference comparing DS to health. 
Conclusions: xerostomia does not appear to be associated with the presence of DS. Denture 
levels of yeast were higher and more strongly predictive of clinical DS than salivary or 
mucosal levels, suggesting that the denture, rather than the inflamed palatal mucosa, was the 
dominant C. albicans habitat.   
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Introduction 
There are conflicting data regarding the etiology and pathogenesis of denture stomatitis (J. 
Barbeau, et al. ,2003, E. Budtz-Jorgensen. ,1990, C. G. Cumming, et al. ,1990, R. T. Glass, et 
al. ,1990, B. C. Webb, et al. ,1998a, B. C. Webb, et al. ,1998b). Several hypotheses have 
been offered as plausible etiologic and contributing factors in denture stomatitis depending 
on the fact that these factors cause an overgrowth of commensal microbes, especially yeasts 
such as candida, and of Gram negative anaerobes. The overgrowth of such oral pathogens has 
been suggested to be potentially due to impaired salivary flow and function, tissue trauma as 
a result of ill-fitting dentures, poor denture and oral hygiene and impaired immune response 
secondary to systemic conditions. Indeed, the higher prevalence of DS among immune-
compromised individuals who are more susceptible to opportunistic yeast infections (e.g. 
diabetic subjects), coupled with the clinical evidence that antifungal agents can reduce 
musosal inflammation associated with DS provides strong evidence of the key role of fungal 
infections as potentially etiologic factor. However, after a course of antifungal therapy, the 
condition often returns even among immunocompetent individuals, and not all DS patients 
respond to antifungal therapy,  In those refractory individuals, antibiotics have been reported 
to provide resolution, suggesting that anaerobic pathogens may potentially play a role under 
some circumstances (E. Budtz-Jorgensen, et al. ,1983, A. S. Koopmans, et al. ,1988, C. 
Pesci-Bardon, et al. ,2004, S. Redding, et al. ,2009). Thus, Gram negative anaerobes may 
also be important in the pathogenesis of DS.  Although mucosal surfaces can harbor low 
levels of fungal microbes as well as anaerobic pathogens similar to those associated with 
periodontal diseases (A. Sachdeo, et al. ,2008), the denture can serve as a habitat for a high-
density biofilm which can harbor high levels of bacteria and yeasts (A. Sachdeo, et al. ,2008, 
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B. J. Coco, et al. ,2008, G. Ramage, et al. ,2004).  Thus, the denture itself is believed to serve 
as a reservoir for triggering a local microbial infection-mediated inflammatory response.  It 
should be noted, however, that these statements regarding etiology and effects of treatment 
are based upon data from relatively few case series and small single-centered trials.  
The role of Candida is also controversial. Certain strains of Candida, specifically hyphal-
forming clonal types, are more commonly found in mucosal infections and appear to be 
virulent because these strains are capable of epithelial binding, disruption of epithelial 
integrity and invasion (C. Salerno, et al. ,2010, G. Dahlen, et al. ,2009, H. Bilhan, et al. 
,2009, J. E. Leigh, et al. ,2002, H. Nikawa, et al. ,2002, A. Rodriguez-Archilla, et al. ,1996).  
Overgrowth of Candida in DS is a common finding, and can be a precursor to oropharengeal 
candidiasis which can become a life-threatening disseminating infection among HIV/AIDS 
subjects and other immunocompromised conditions, especially those conditions that are 
associated with T cell functional deficits (J. E. Leigh, et al. ,2002, H. Nikawa, et al. ,2002, A. 
Rodriguez-Archilla, et al. ,1996).  But the ecological pressures that cause the emergence of 
oral Candida and its role in pathogenesis in a normally healthy individual are less well 
understood. Antibiotic usage, especially prolonged suppression, can cause a shift in the oral 
flora and a fungal overgrowth.  Impaired salivary flow or altered salivary composition, which 
may or may not be associated xerostomia syptomology, has been suggested to lead to a shift 
in the oral microbiome composition that favors fungal overgrowth. The association between 
the symptom of “dry mouth” and the amount of saliva flow are not necessarily concordant. 
Furthermore, salivary glycosaminoglycan content, as reflected in viscosity measures, does 
not agree well with xerostomia symptoms {{1541 Higuchi,Y. 2009; 1542 Wolff,M. 1998}}. 
Salivary secretory IgA level is a critical modulatory of microbial aggregation, microbial (Y. 
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Higuchi, et al. ,2009, M. Wolff, et al. ,1998) clearance and surface adherence. Thus, impaired 
sIgA has been attributed to microbial overgrowth (C. Fukushima, et al. ,2005, S. Hagewald, 
et al. ,2002, T. Tanida, et al. ,2003). The relation between salivary flow and viscosity has 
been suggested to also potentially play a role in DS by altering the epithelial resistance to 
Candidal binding and invasion. 
In this study, we aimed to examine the association between clinical signs of DS (measuring 
the severity of stomatitis with the Newton Score and the Denture fit using the Kapur index) 
and  1) the exfoliative cytology, 2) the microbial levels (bacteria and yeasts) present in saliva, 
on mucosal tissues and on denture surfaces, and 3) the salivary flow rate and xerostomia 
symptoms, that discriminate between DS and health.  
Materials and methods 
Study design, Subjects and Sample Size Estimates 
This was a case control study design intended to collect biological samples from participants 
without and with denture stomatitis, specifically with mucosal lesions (Newtons 
Classification  Type II or Type III).   
A total of 32 edentulous subjects were enrolled according to the inclusion and exclusion 
criteria listed in Table 1-1. The control group (n=17) had no signs or symptoms of denture 
stomatitis (DS), and the diseased group (n=15) presented with type II (n=8) or III (n=7) DS 
(Newton‟s classification) (A.V. Newton 1962). This level of DS includes the moderate (Type 
II) and severe (Type III) forms. Representative clinical appearance of cases and controls 
appear in Figure 1-1. All subjects that were enrolled completed the two visit study.  For all 
parameters of interest there was no apparent gradient progressing from health to type II to 
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Type III, therefore the Type II and Type II remained grouped as a single DS diseased group, 
as initially intended. 
This was an exploratory study and a targeted sample size of 30 (15 subjects per group) was 
determined to provide 80% power with two-sided alpha = 0.05 significance tests to detect 
changes in means from continuous variables between diseased and non-diseased subjects that 
are 1.06 times the standard deviation of the variable.  The sample size was considered 
sufficient as effect sizes such as this, or larger, are common for levels of dental biofilm 
organisms and pro-inflammatory cytokines. To allow for an 8-10% possible drop-out rate, 32 
subjects were enrolled to ensure that 30 (15 subjects per group) completed the study. In this 
report we limit the analyses to the clinical findings, the cytology and the cultivable data. 
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Table 1-1. Inclusion and exclusion criteria 
 
 
Inclusion cri teria  
 
1.  At least  45 years of age  
2. Male or females  without 
menses for 12 consecutive 
months or  who have had a 
complete hysterectomy 
3. Wear complete maxi llary 
denture (overdentures,  implant or 
tooth retained dentures 
acceptable) without daily use of 
denture adhesive.  
4. Must have read, understood 
and signed an informed consent 
form.  
5. Must understand and be 
will ing to comply with all  study 
procedures and restric t ions  
6. Must be in good general  
health;  diabetics included 
7. Must have Type II or Type III 
denture stomatit is for denture 
stomatit is group 
8. Must have no signs of denture 
stomatit is for control  group  
 
Exclusion cri teria  
 
1.  Less than 45 years of age.  
2. Have chronic disease with oral  manifestations 
other than denture/mucosal stomatit is.  
3.  Have gross oral  pathology.  
4. Have overt  denture abrasion associated with 
symptoms.  
5. Participants with cl inically significant organic 
diseases, including impaired renal function, 
bleeding disorder,  or any condition requiring 
antibiotic pre -medication for dental  visi ts  
6. Participants with active infectious diseases 
such as hepati t is,  HIV or tuberculosis.  
7.  Participants who are immunosuppressed 
because of medications or condition.  
8. Participants who have used antibiotics or 
antifungals for any medical  or dental  condition 
within 1 month prior to screening.  
9. Participants using ongoing medications 
init iated less than 3 months prior to enrollment.  
10.Participants with a  known or suspected 
intolerance to local  oral  anesthesia.  
11.Participants who have participated in another 
clinical  study or  have taken an investigational 
drug within 30 days of screening.  
12.Participants who have used tobacco products 
within 6 months of screening.  
13.Employees of the sponsor or the investigator 
or members of their  immediate family.  
14.Participants who have previously participated 
in this study.  
15.Post -menopausalwomen on hormone 
replacement therapy.  
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Figure 1-1. Clinical photographs of (A) a control subject, (B) Newton classification 
               II stomatitis, and (C) Newton classification III stomatitis. 
 
 
Clinical evaluation of dentures (Kapur Index)  
 
A qualified examiner (prosthodontist) assessed the fit of the maxillary and mandibular 
dentures (if present) using the Kapur Index (K. K. Kapur. ,1967)as following: 
Retention: 
3: Good – maximum resistance to vertical pull and sufficient lateral force.   
2: Moderate – moderate resistance to vertical pull and little or no resistance to 
lateral force. 
1: Minimum – slight resistance to vertical pull and little or no resistance to 
lateral force. 
0: No retention – denture displaces itself. 
Stability: 
2: Sufficient –demonstrates slight or no rocking on its supporting structures 
under pressure. 
1: Some –demonstrates moderate rocking on its supporting structures under 
pressure. 
0: No stability – demonstrates extreme rocking on its supporting structures under 
pressure. 
 
Since not all of the subjects had a mandibular denture, mean values for the total scores of 
retention and stability for the maxillary denture were calculated.  
Clinically poor denture = sum score of<3 
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Clinically fair denture = sum score of 3-4. 
Clinically good denture = sum score of >4.  
Unpaired T-test was performed to assess statistical difference between means of scores of the 
maxillary dentures for DS and healthy groups. 
Unstimulated Saliva Collection 
Subjects were instructed to remove their dentures and refrain from eating, drinking, smoking, 
brushing their teeth or chewing gum 15 minutes prior to salivary collections. All collections 
were performed between 9:00 and 11:00 AM. Subjects were instructed to swallow to clear 
the mouth of any accumulated saliva, and whole unstimulated saliva was allowed to pool in a 
sterile polypropylene graduated collection vial for 5 minutes. A fraction of the sample was 
sent immediately to the microbiology lab for rapid processing to prevent overgrowth of the 
Candida species. Samples were aliquoted into Eppendorf tubes, centrifuged for 10 minutes at 
3000g, and the supernatant stored at -80
°
C for proteomic and cytokine analysis. 
Stimulated Saliva Collection 
Subjects were instructed to place their dentures back before the collection begins.  Stimulated 
whole saliva was quantified by using a modification of the Saxon test. (Kohler PF, Winter 
ME, 1985) where each participant was  asked to chew on a folded strip of paraffin for 2 
minutes after swallowing to clear the mouth of the accumulated saliva. The collected saliva 
was then quantified as milliliters of saliva generated per minute (ml/min) and recorded on the 
CRF. Participants found to have a resting (unstimulated) saliva rate of less than 0.01 ml/min 
and stimulated salivary rate of less than 0.10 ml/min were characterized as having 
hyposalivation (M. Bergdahl, et al. ,2000, M. Bergdahl. ,2000) 
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Xerostomia questionnaire 
Subjects were asked to complete the xerostomia questionnaire (Table 2) after the salivary 
collection. This questionnaire is derived from the validated questionare from the Dental 
ARIC study as described by Beck etal (J. D. Beck, et al. ,2001). Analysis of variance (items # 
3, 13 and 14) and Spearman correlations (items #5-12) by regression analysis were used to 
analyze relationships between salivary flow rates and subject-reported symptoms of dry 
mouth.  
Mucosal Wetness 
Subjects were instructed to swallow and sialopaper was placed on the midline of the anterior 
third of the dorsum of the tongue for 5 seconds. Sialopaper was then transferred to Periotron 
(Model 6000) for reading and after reading the sialopaper was discarded. Measurement was 
done 2 times. T-test was used to determine differences between the means of readings 
comparing groups. 
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Table 1-2. Xerostomia questionnaire. 
1) Do you have any difficulties in swallowing any foods? (yes/no) 
2) Does your mouth feel dry when eating a meal? (yes/no) 
3) Do you sip liquids to aid in swallowing food? (yes/no) 
4) Does the amount of saliva in your mouth seem to be too little, too much, or 
you don‟t notice it? 
5) Rate the difficulty you experience in speaking because of dryness in your 
mouth. (1-10 scale). 
6) Rate the difficulty you experience in swallowing because of dryness in your 
mouth. (1-10 scale). 
7) Rate how much saliva is in your mouth. (1-10 scale). 
8) Rate the dryness of your mouth. (1-10 scale). 
9) Rate the dryness of your throat. (1-10 scale). 
10) Rate the dryness of your lips. (1-10 scale). 
11) Rate the dryness of your tongue. (1-10 scale). 
12) Rate the level of your thirst. (1-10 scale). 
13) Dryness of lips (present or absent). 
14) Dryness of buccal mucosa/ cheek areas (present or absent). 
 
Exfoliative Examination 
Smears were taken from the affected palatal mucosa and unaffected palatal mucosa for the 
stomatitis group, and only one sample from the palatal mucosa for the control group. 
Samples were taken from the buccal vestibular area and dorsum of the tongue as well. 
Subjects with dry mouth (xerostomia) were instructed to rinse with a small amount of water 
prior to collection of the sample. Selected areas were wiped firmly, using a wooden tongue 
blade, until there was a visible accumulation of oral fluids present. Accumulated samples 
were transferred to a clean glass slide until there is a thin coat visible when the slide is held 
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against light. Slides were then sprayed with Cytofix/Cytoperm
™
 with one or two swipes from 
a distance of about 1 foot and allowed to dry for 10 minutes. 
When adequate samples could not be collected using this procedure, the sampling steps 
outlined above were repeated in a different area of the palatal mucosa, until an adequate 
sample was collected.   
These Samples were used for cytology and PAS identification of fungal forms. The 
following scoring system was used for the PAS-cytology assessments: 
0= INADEQUATE CELL SAMPLE, 1=BENIGN SMEAR, 2=BACTERIA ONLY, 3=BENIGN 
INFLAMMATORY SMEAR, 4=BACTERIA PLUS INFLAMMATORY CELLS, 5 = FUNGAL SPORES, 
6= FUNGAL ORGANISMS. 
Culture  
BBL
™
CultureSwab
™
 was used to swab the denture and the mucosal surface, with total of 3 
swabs for the diseased group (from the denture, mucosal surface of affected area and 
unaffected area), and two swabs for the control group (from the denture and the mucosal 
surface). 
Samples were cultured on Sabouraud Dextrose agar containing quemicetine succinate. 
Samples were spiral plated to Sabaroud‟s dextrose plates to obtain a quantitative value of 
CFU/ml.  Samples were also plated on a total aerobic plate to compute the percentage of total 
aerobic recoverable CFU on a non-selective medium to allow for identification of both 
albicans and non-albicans Candida.   Candida colonies were counted after 48 h and the 
                                                     
™
Cytofix/Cytoperm is a trademark of Becton, Dickinson and Company. 
™
 BBL is a trademark of Becton, Dickinson and Company. 
™
CultureSwab is a trademark of Becton, Dickinson and Company. 
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patients classified according to the number of CFU (Colony-forming units) as follows: 
negative (CFU/ml = 0), carrier (CFU/ml < 400), and positive (CFU/ml > 400). 
A fraction of the UWS was sampled in Sabouraud Dextrose agar containing quemicetine 
succinate, and Candida colonies were counted after 48 h and the patients classified in the 
same way as for the BBL culture swabs. 
Results 
Demographics 
The mean age of the 32 participants was 64.8. The control group was comprised of 14 
females, 3 males, 11 Caucasians, and 6 African Anericans. The stomatitis group was 
comprised of 9 females, 6 males, 9 Caucasians, 3 African Anericans, and 3 Asians. There 
were no significant differences in age, race or gender comparing the DS vs control groups. 
Baseline characteristics and Kapur index results are included in Table 1-3 and show no 
significant differences between groups. 
Table 1-3. Demographics and baseline characteristics of the subjects. 
 Control (n=17) DS (n=15) 
Age (mean ± SD) 66.2±9.7 63.2±8.83 
Gender 
      Male                                     3 (17.6%)                                           6 (40%) 
      Female                                 14 (82.4%)                                          9 (60%) 
Race 
      Caucasian                             11 (64.7%)                                          9 (60%) 
      African American                 6 (35.3%)                                            3 (20%) 
      Asian                                                                                                 3 (20%) 
Kapur index of max.                   3.56 ± 1.46                                       3.00 ± 1.57 
Denture (mean ± SD) 
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Salivary Flow Rates 
There was no significant difference in the rate of stimulated or unstimulated salivary flow 
comparing Healthy individuals to DS patients. Table 1-4. 
Table 1-4. Flow rate of unstimulated and stimulated whole saliva in contro, and DS subjects. 
Subjects Salivary flow (ml/min) 
       UWS (mean±SD)                     SWS (mean±SD) 
Control (n=17) 0.5 ± 0.23 1.43 ± 0.57 
DS type II (n=8) 0.5 ± 0.15 1.14 ± 0.43 
DS type III (n=7) 0.55 ± 0.23 1.34 ± 0.57 
P value (ANOVA) 0.84 0.46 
DS combined (n=15) 0.53 ± 0.19 1.23 ± 0.5 
P value ( unpaired T-test) 0.71 0.31 
 UWS: unstimulated whole saliva collected for five minutes. 
 SWS: stimulated whole saliva collected by chewing folded strip of paraffin for 
two minutes. 
 Hyposalivation: unstimulated saliva rate of less than 0.01 ml/min, and stimulated 
saliva rate of less than 0.10 ml/min. 
Xerostomia Symptoms  
There was no significant difference in the frequency of reported dry mouth comparing DS to 
control subjects. However, among all subjects there were significant associations between 
symptomology and flow and wetness measures. A significant correlation was found between 
unstimulated salivary flow rate and perceived “Rate the dryness of your tongue”, (r2 = 0.36, 
p=0.0405). There was also a significant association between stimulated salivary flow rate and 
“Rate the level of your thirst”, (r2=0.51, p =0.0028). All other correlations were not 
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significant and were in the range of (-0.23 to 0.10). For questions #3, 13, and 14 there were 
no significant associations between the reported symptoms and the flow rate of both 
unstimulated and stimulated saliva. 
Cytology 
According to the cytology results of the palatal mucosal swabs (figure 1-2, Table 1-5), it was 
noticed that Type II and Type III DS are associated with higher scores reflecting 
inflammatory cells, bacterial and fungal morphotypes. Inflammatory cells in the palatal 
mucosa showed significant difference (P=0.02) between DS and control subjects. It is 
noteworthy that fungal forms were often found in control subjects. There was no statistically 
significant difference in the cytology of the vestibular and tongue swabs comparing DS Type 
2 or DS Type 3 to Health. However, the vestibular area and the tongue as well as the palate 
had a trend for more prevalent fungal forms in DS subjects. 
Figure 1-2. PAS exfoliative cytology representative slides.(A) a healthy control benign  
smear, (B) DS fungal hyphae. 
A) Oral cytologic smear of palatal mucosa showing typical squamous cells and scattered     
chronic inflammatory cells. (10 X) 
B) Oral cytologic smear from palatal mucosa showing candidal hyphae. (40X)  
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Table 1-5. PAS exfoliative cytology results for palatal, and vestibular area and tongue.  
 Palatal Area Vestibular Area and Tongue 
 Healthy Diseased p-
value 
Healthy Diseased p-
value 
Adequate (Yes) 12 (44.4%) 15 (55.6%)  17 (53.1%) 15 (46.9%)  
  No 5 (100.0%) 0 (0.0%) 0.02 .. .. .. 
Bacteria (Yes) 6 (40.0%) 9 (60.0%)  12 (46.2%) 14 (53.9%)  
  No 11 (64.7%) 6 (35.3%) 0.16 5 (83.3%) 1 (16.7%) 0.10 
Inflammatory Cells (Yes) 0 (0.0%) 4 (100.0%)  3 (37.5%) 5 (62.5%)  
  No 17 (60.7%) 11 (39.3%) 0.02
* 
14 (58.3%) 10 (41.7%) 0.31 
Fungal Spores (Yes) 5 (35.7%) 9 (64.3%)  12 (46.2%) 14 (53.9%)  
  No 12 (66.7%) 6 (33.3%) 0.08 5 (83.3%) 1 (16.7%) 0.10 
Fungal Hyphae (Yes) 4 (40.0%) 6 (60.0%)  7 (43.8%) 9 (56.3%)  
  No 13 (59.1%) 9 (40.9%) 0.32 10 (62.5%) 6 (37.5%) 0.29 
Atypical Cells (Yes) 0 (0.0%) 1 (100.0%)  .. ..  
  No 17 (54.8%) 14 (45.2%) 0.28 17 (53.1%) 15 (46.9%) .. 
Score       
  Inadequate Cell Sample 6 (100.0%) 0 (0.0%)  .. ..  
  Benign Smear 4 (57.1%) 3 (42.9%)  4 (100.0%) 0 (0.0%)  
  Bacteria Only 2 (50.0%) 2 (50.0%)  1 (50.0%) 1 (50.0%)  
  Benign Inflammatory Cells 0 (0.0%) 1 (100.0%)  .. ..  
  Bacteria plus Inflammatory 
Cells 
.. ..  .. ..  
  Fungal Spores 1 (25.0%) 3 (75.0%)  5 (50.0%) 5 (50.0%)  
  Fungal Organisms 4 (40.0%) 6 (60.0%) 0.13 7 (46.6%) 8 (53.3%) 0.28 
Score Dichotomized (Fungal) 5 (35.7%) 9 (64.3%)  12 (48.0%) 13 (52.0%)  
  No Fungal 12 (66.7%) 6 (33.3%) 0.08 5 (83.3%) 1 (16.7%) 0.12 
 Statistically significant (P< 0.05) 
 
Cultivable C. albicans levels in saliva and on Denture and Mucosal Surfaces 
In the saliva, C. albicans was detected in 80% (12/15) of the DS subjects, but only 41.2% 
(7/17) of the control subjects (p=0.03, Chi Square). There was no greater detection rate of C. 
albicans in severe DS as compared to mild DS. In the dentures, C. albicans was present in 
73.2% of dentures sampled from DS subjects and only in 11.8% of dentures sampled from 
healthy individuals (p=0.002), Chi Square. In the mucosa there was no significant difference 
in C. albicans counts between diseased (P=0.27) and healthy mucosa (p=0.2). There was a 
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high degree of concordance between the presence of C. albicans in the saliva vs that 
detectible on the denture (r
2
=0.31, p=0.0007). C. albicans prevalence by location comparing 
saliva vs healthy mucosa was not significant (p=0.059), nor was it significant when 
compared to diseased mucosa (p=0.79). 
Non-albicans Candida was also significantly detected especially in DS subjects. Table 1-6 
shows the prevalence of both C. albicans and Non-albicans in all subjects. 
Table 1-6. Prevalence of C.Albicans and Non-Albicans in Saliva, denture, and mucosal 
surfaces for control and DS subjects.  
 Saliva (N=32) Denture (N=32) Unaffected Mucosa 
(N=32) 
Affected Mucosa 
(N=15) 
 C.Albicans Non-
Albicans 
C.Albicans Non-Albicans C.Albicans Non-
Albicans 
C.Albicans Non-
Albicans 
Control 
(N=17) 
7 (41.2%) 7 (41.2%) 2 (11.8%) 8 (47.1%) 1 (5.9%) 7 (41.18%)   
DS type 
II (N=8) 
7 (87.5%) 0 (0.00) 6 (75.0%) 0 (0.00%) 2 (25.0%) 2 (25.0%) 2 (25.0%) 3(37.5%) 
DS type 
III (N=7) 
5 (71.4%) 0 (0.00) 5 (71.4%) 2 (28.6%) 2 (28.6%) 4 (57.1%) 4 (57.1%) 3(42.9%) 
Total 
(N,%) 
19(59.4%) 7 (21.9%) 13 
(40.6%) 
10(31.3%) 5 (15.6%) 13 (40.6%) 6 (40.0%) 6(40.0%) 
P values 0.03* 0.02* 0.002* 0.06* 0.27 0.45 0.20 0.83 
 Statistically significant (P< 0.05) 
 
 
Discussion 
The role of xerostomia as an etiological factor in denture stomatitis has been a subject of 
controversy for many years. In this study, there was no difference in the frequency of 
reported dry mouth, or in the rate of stimulated or unstimulated salivary flow comparing 
control individuals to DS patients. In fact, most of the subject-reported symptoms of dry 
mouth did not correlate with saliva flow. Torres et al (S. R. Torres, et al. ,2003, T. Pereira-
Cenci, et al. ,2008) found that 67.9% of the individuals with xerostomia were colonized by 
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Candida spp.; however, the difference between these patients and those without xerostomia 
was not statistically significant. Närhi et al (T. O. Narhi, et al. ,1993) found significantly 
higher counts of yeasts in individuals with salivary flow rates below normal. According to 
Tatiana et al (T. Pereira-Cenci, et al. ,2008) patients with low or impaired salivary flow 
and/or composition presented higher Candida species counts when compared with saliva 
from patients with normal salivary flow. Hibino et al (K. Hibino, et al. ,2009)reported that 
both stimulated and unstimulated salivary flow rates of the non-carriers were higher than the 
carriers although the difference was not statistically significant. 
In their study to determine risk factors associated with oral candidiasis onset and chronic 
maintenance, Campisi et al (G. Campisi, et al. ,2008) found both denture wearing and 
xerostomia to be local risk factors according to their analysis. The sample size in our study is 
too small to refute or resolve any of these conflicting findings. One key issue is that the 
typical assessments of salivary function from a physiological perspective (e.g. salivary flow 
rate, mucosal wetness, xerostomia symptoms) may not be associated with the antifungal 
capacity of the saliva. Clearly, future studies which intend to examine the role of salivary 
immunoglobulins (e.g. sIgA) and specific anti-fungal components, such as lactoferrin, 
histatin-5, lysozyme, and histidine-rich polypeptides in recoverable yeast counts, in addition 
to physiological assessments would be informative.  
Role of Candida 
In this study C. albicans was approximately twice as likely to be present in saliva of DS 
subjects (80%) as compared to control subjects (41.2%).  However, there was no clear trend 
for the CFU levels of salivary C. albicans to show a gradient of higher numbers associated 
with the transition from Type II to Type III DS.  
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A strong relationship between DS and the presence of Candida in saliva has been reported 
previously (I. Berdicevsky, et al. ,1980, B. C. Webb, et al. ,1998). On the other hand, patients 
with Candida in saliva may not develop DS (J. Wilson. ,1998) and this is in agreement with 
our findings. Since the frequency of detection of C. albicans is lower on the denture (11.8%) 
than present in the saliva (41.2%) of control subjects, it would appear that saliva and/or 
mucosa represents the reservoir of infectious agent in these healthy individuals and that the 
denture is less frequently colonized with C. albicans. According to Pires (F. R. Pires, et al. 
,2002), the clinical resolution of Denture stomatitis was not related to the levels of Candida 
in saliva and, furthermore, a decrease of Candida counts in saliva usually is not followed by 
clinical improvement of DS.   
In our study, there was a significant difference in the C. albicans prevalence in denture 
surfaces between DS and control subjects (p=0.03). C. albicans was 20.6 fold more likely to 
be cultured from the denture in DS patients compared to healthy. The notion that greater 
numbers of candida spp. were recovered from smears prepared from the fitting surfaces of 
the dentures than from those on the palatal mucosa has been known since the 1970‟s (J. C. 
Davenport.,1970, H. Lamfon, et al. ,2005). It has been shown that C. albicans colonies were 
recovered more frequently from the tissue fitting surface of the acrylic resin denture than 
from the corresponding palatal mucosa in DS subjects (B. C. Webb, et al. ,1998). However, 
according to Radford (D. R. Radford, et al. ,1999)it is difficult to attribute the etiology of the 
condition entirely to the presence of C. albicans in denture plaque as they found in their 
review that methods of sample collection accounted for individual variation, since palatal 
imprints yielded 55% of subjects with yeast present, denture plaque sampling 80%, and 
saliva sampling 95%. Interestingly, in our study we found a high degree of concordance 
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between the presence of C. albicans in the saliva vs. that detectible on the denture (r
2
=0.31, 
p=0.0007). It was also noticed that non-albicans species are more prevalent in control 
subjects especially upon comparing prevalence in the unaffected mucosa in these subjects. 
However, whether non-albicans presence in patient‟s saliva or mucosa is associated with any 
protective effect or not, can‟t be withdrawn as a conclusion from this small cohort. 
 
Exfoliative Cytology Findings in DS 
Reports have been variable on whether the inflammation associated with denture stomatitis is 
secondary to denture trauma or it‟s just a result of candidal infection. According to Barbeau 
(J. Barbeau, et al. ,2003),  the presence of yeasts on the denture in denture-related stomatitis 
is probably linked to extensive inflammation. Considering the hypothesis that inflammation 
could be present before Candida colonization, this could explain the variable results in the 
treatment of denture-related stomatitis with antifungal treatment alone (J. Barbeau, et al. 
,2003). In a randomized clinical trial looking at frequency of DS in patients with mandibular 
two-implant overdentures as opposed to conventional dentures opposing conventional 
maxillary denture, Emami et al reported that inflammation due to trauma may create an 
environment favorable to micro-organisms found in denture stomatitis. 
According to Edgerton (M. Edgerton, et al. ,1992), the pathogenesis of stomatitis may be 
through two separate mechanisms. Alterations in the composition of pellicle formed in 
stomatitis conditions, such as degradation of pellicle components, may directly promote 
colonization of C. albicans on “stomatitis” pellicle. Alternatively, C. albicans may be a 
secondary colonizer or may require bacterial cell products to stimulate adhesion as has been 
shown within vitro studies of Streptococcus mutans and C. albicans (C. Branting, et al. 
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,1989) . In this case, altered pellicle deposition in the disease process may initially enhance 
adhesion of other bacteria, which would subsequently promote adhesion of Candida. (M. 
Edgerton, et al. ,1992) 
In a study by Ritchie et al. it was found that bacteria, leukocytes and yeast hyphae could be 
detected in all patients even when cultures were negative (G. M. Ritchie, et al. ,1969).  
Examination of Periodic acid Schiff (PAS) stained smears prepared from denture scrapings 
showed higher number of yeast cells in DS patients by (E. Budtz-Jorgensen, et al. ,1983) as 
well. However, in our study the presence of hyphae, as determined from the PAS smear from 
tissue was not pathognomic for disease. 
 
Conclusions: 
hyposalivation, impaired mucosal wetness or xerostomia symptomology does not appear to 
be associated with the presence of DS. C. albicans counts in saliva and on denture surfaces 
were significantly elevated in DS as compared to health. Denture levels of yeast were higher 
and more strongly predictive of clinical DS than salivary or mucosal levels, suggesting that 
the denture, rather than the inflamed palatal mucosa, was the dominant C. albicans habitat.   
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Abstract: 
Purpose: The aim of this study was to explore the microbial and inflammatory 
characteristics associated with Denture Stomatitis by characterizing 1) the levels of salivary 
cytokines and salivary cultivable C. albicans, 2) the composition of the biofilm attached to 
the tissue-bearing denture surfaces as determined by DNA-DNA checkerboard analyses and 
3) the serum C-reactive protein levels as a marker of systemic inflammation.  
Methods: Thirty-two subjects were enrolled in a case-control study with a control group 
(n=17), and a diseased group (n=15) with type II and III denture stomatitis (DS) (Newtonʼs 
classification). Samples of unstimulated whole saliva (UWS), serum and swabs from denture 
surfaces were collected. Salivary levels of certain inflammatory mediators and serum levels 
of C-reactive protein were measured by flow multiplex analyses. Salivary cultivable levels of 
C. albicans were expressed as colony-forming units. Samples from denture and mucosal 
surfaces were analyzed with DNA-DNA checkerboard. 
Results: In salivary samples from DS subjects there was a two fold increase in levels of IL-8 
(p=0.04) and a 1.8 fold increase in IL-1 (p=0.04) with non-significant trends for increases in 
IL-1, TNF and IL-6. In DS C. albicans was found in significantly higher counts in saliva 
(p=0.03) and there was a significant association between salivary C. albicans CFU and levels 
of both IL-8 (r
2
=0.16, P=0.03), and IL-1α (r2=0.20, P=0.01)   There were no significant 
differences in the serum CRP levels (p=0.74). Although previous studies using cultivable
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 methods had demonstrated the presence of periodontal pathogens on denture surfaces, using 
curette samples and DNA-DNA checkerboard analyses we found that typical periodontal 
pathogens were generally below the detection threshold of 10
4
 organisms on both denture 
and inflamed mucosal surfaces. 
Conclusions: 
The data suggest that denture stomatitis is associated with significant salivary elevation of 
the levels of the chemokine IL-8, as well as increased levels of cultivable C. albicans. In 
denture stomatitis there was no evidence of systemic inflammation as measured by serum C-
reactive protein levels. The findings from this relatively small exploratory study should be 
interpreted with caution but provide observations for future investigation. 
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Introduction 
Candida-associated denture stomatitis (CADS) is the most common form of oral candidal 
infection in denture wearers, (B. C. Webb, et al. ,1998) with Candida albicans being the 
principal etiological agent  (E. Budtz-Jorgensen. ,1990),(J. Chandra, et al. ,2001). CADS has 
been reported in 11%-67% of the otherwise healthy denture wearers (G. Ramage, et al. 
,2004),  and has been classified according to Newton‟s work in 1962 into 3 clinical types: 
Type I - a localized simple inflammation or a pinpoint hyperemia; Type II (mild) : an 
erythematous or generalized simple type presenting as more diffuse erythema, and Type 
III(severe): a granular or papillary type (A.V. Newton 1962). This condition has been 
considered to have a multifactorial etiology, which can include factors related to 1) trauma 
such as denture wearing, 2) local trauma resulting from salivary hypofunction (J. P. Lyon, et 
al. ,2006),(C. M. Abraham, et al. ,1998), 3) infection with candida species, or 4) factors 
related to impaired host defense as in systemic diseases such as HIV infection, leukemia, 
lymphoma, radiation therapy for head and neck malignancies, chemotherapy, diabetes, 
hormonal imbalance, anemia, malnutrition, or long-term use of corticosteroid or antibiotics. 
The multi-factorial etiology for denture stomatitis is reflected in the current treatment 
regimens which varies from antifungals(B. C. Webb, et al. ,1998), to denture hygiene 
measures, antiseptics, and use of denture reline materials containing antifungals (A. N. 
Ellepola, et al. ,2000). 
Although some progress has been made in revealing the mechanisms of epithelial and 
immunoregulatory interactions with Candida, there are major gaps in our knowledge 
regarding processes that lead to the establishment of candidiasis as an infection and the 
relationship between mucosal and systemic inflammatory responses. Primary innate defense 
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mechanisms are known to play key roles in preventing yeast colonization of the oral cavity 
(R. D. Cannon, et al. ,1995). During oral infection with Candida, a large number of pro-
inflammatory and immunoregulatory cytokines such as IL1α, IL1ᵦ, IL8, and TNFα, are 
generated by the oral mucosa (C. C. Villar, et al. ,2008, A. Dongari-Bagtzoglou, et al. ,2005, 
M. Schaller, et al. ,2004). The main sources of these cytokines have been reported to be of 
oral epithelial cells. Although infiltrating neutrophils are likely important contributors.  
Cytokines in saliva are also derived from salivary gland cells (secretory,epithelial cells, 
fibroblasts, endothelial cells), and leukocyte aggregates within the salivary gland tissues, 
tonsils, and the oral mucosa , including the periodontium. Therefore, cytokine profiles in 
whole saliva can depict the collective state of cytokine responses to infectious agents by all 
tissues in the oral cavity, including accessory salivary glands which are major contributors of 
secretory IgA(A. Dongari-Bagtzoglou, et al. ,2005). However, the influence of whole saliva 
composition on candida adherence and invasion is yet to be fully understood.  
Biofilms are structured microbial communities in which the cells bind tightly to a surface and 
become embedded in a matrix of extracellular polymeric substances produced by these cells. 
Indeed components of saliva or serum proteins, such as mucin, fibrinogen and 
complementary factors specifically bind to Candida blastospores and germ tubes, possibly 
modifying the biofilm formation(H. Nikawa, et al. ,2000). Biofilms of differing compositions 
colonize oral surfaces including the teeth, the mucosa, the tongue and acrylic denture 
surfaces. These self-replenishing biofilms gain notoriety from their ability to resist 
antimicrobials and immune cell challenge (J. Nett, et al. ,2006, G. Ramage, et al. ,2001) .  
The purpose of this study was to identify the candidate inflammatory mediators present 
within the saliva of DS subjects. We sought to confirm previous reports establishing the 
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relationship between DS and increased salivary levels C. albicans and to determine if the 
level of C. albicans was associated with the levels of salivary cytokine biomarkers. Finally, 
since DS is such a common infection among edentate people we accessed whether there was 
any evidence of systemic inflammatory response as indexed by serum levels of C-reactive 
protein. Although this was a relatively small exploratory pilot investigation, the data suggest 
that increased levels  of certain salivary cytokines are associated with the presence of DS and 
related to salivary levels of C. albicans. 
Materials and methods  
An IRB approved case-control study was performed. Thirty-two subjects were enrolled and 
grouped into two groups: a control group (n=17) with no signs or symptoms of denture 
stomatitis (DS), and a diseased group (n=15) with type II or III DS (Newton‟s classification). 
Inclusion and exclusion criteria, and demographics of this cohort of patients are described in 
the previous chapter.  
Unstimulated Saliva collection and cytokines analysis:  
Subjects were instructed to remove their dentures and refrain from eating, drinking, smoking, 
brushing their teeth or chewing gum for 15 minutes prior to salivary collections. All 
collections were performed between 9:00 and 11:00 AM. Subjects were instructed to 
swallow to clear the mouth of any accumulated saliva, and whole unstimulated saliva was 
allowed to pool in a sterile polypropylene graduated collection vial for 5 minutes. A fraction 
of the sample was sent immediately to the microbiology lab to prevent overgrowth of the 
Candida species. Samples were aliquoted into Eppendorf tubes, centrifuged for 10 minutes at 
3000g, and the supernatant stored at -80
°
C until analysis. Before cytokines analysis, the 
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samples were thawed and centrifuged for 10 minutes at 3000g to remove any solids. Specific 
proteins (IL-1α, IL-1ᵦ, IL-6, IL-8, and TNFα) levels in Saliva samples were quantified by 
ELISA and/or using the Fluorokine
®
 MAP cytokine multiplex kits and Luminex
®
 analyzer 
system. Protein levels were log-transformed prior to application of multivariate tests 
comparing subjects with denture stomatitis to those without denture stomatitis, and 
comparing diseased and non-diseased sites within subjects with clinical stomatitis. 
A fraction of the unstimulated saliva was sampled in Sabouraud Dextrose agar containing 
quemicetine succinate. Candida colonies were counted after 48 h and the patients were 
classified according to the number of CFU (Colony-forming units) as follows: negative 
(CFU/ml = 0), carrier (CFU/ml < 400), and positive (CFU/ml > 400).  
 
Microbiology 
Four bacterial biofilm samples were collected from the tissue and the corresponding surface 
area of the denture using a plastic curette. The palate was divided into four zones (according 
to the method described by (J. Barbeau, et al. ,2003) figure 2-1, and one biofilm sample was 
collected from each zone and recorded on a diagnostic diagram.The samples were pooled (4 
mucosal samples and 4 denture samples) and placed into a separate Eppendorf tube 
containing 150 L of TE buffer. 150 L of 0.5 M NaOH were added to each sample and 
frozen at -80°C prior to analyses. The pooled biofilm samples were analyzed quantitatively 
and qualitatively to measure the presence, absence and levels of 18 dental biofilm organisms 
by DNA-DNA checkerboard tissue, where median cell count levels of 16 organisms was 
produced for comparison of subjects with clinical stomatitis to those without clinical 
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stomatitis using a nonparametric multivariate test. Mean Candida CFU counts were produced 
for comparison of the diseased and non-diseased groups. 
Figure 2-1.  a diagram showing the division of the palate area into quadrants for bacterial 
biofilm collection from each of the 4 zones .(J. Barbeau, et al. ,2003) 
 
 
 
                                               
DNA-DNA Checkerboard 
Sample deposition on nylon membranes 
The samples were boiled in a water bath for 5 minutes and neutralized using 0.8 ml 5 M 
ammonium acetate. The released DNA was placed into the slots of a Minislot device 
(Immunetics, Cambridge MA) and thereby deposited as “lanes” onto a (formerly Boehringer 
Mannheim, now Roche Diagnostics nylon membrane). The DNA was then permanently fixed 
to the membrane by exposure to ultraviolet light, followed by baking at 120C, for 20 min. 
The Minislot device permits the deposition of up to 30 different bacterial samples in 
individual “lanes” on a single 15 x 15 cm nylon membrane. In order to create reference 
signals on each membrane, two of the „lanes‟ were used to deposit pooled DNA of known 
bacterial numbers (10
5
 and 10
6
) for each one of the microorganisms included in the analysis. 
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DNA-DNA hybridization 
The membranes were prehybridized in “prehybridization” buffer [50% formamide, 5 x SSC 
(1 x SSC = 150 mM NaCl, 15 mM Na citrate, pH 7.0), 1% casein (Sigma), 5 x Denhardt's 
reagent, 25 mM sodium phosphate (pH 6.5) and 0.5 mg/ml yeast RNA (Boehringer-
Mannheim)], at 42C, for 1 hour and then placed back into a "Miniblotter 45", turned 90 to 
the original orientation. A 30 x 45 "checkerboard" pattern was produced. Digoxigenin-
labeled DNA probes dissolved in “hybridization” buffer [45% formamide, 5 x SSC, 1 x 
Denhardt's reagent, 20 mM Na phosphate (pH 6.5),0.2 mg/ml yeast RNA, 20 ng/ml of 
labeled probe, 10% dextran sulfate and 1 % casein], were laid in individual lanes of the 
Miniblotter and the whole apparatus was placed in a sealed plastic bag. Hybridization was 
allowed to occur overnight, in a shaking water bath, at 42C. Membranes were then washed 
once at low stringency to remove loosely bound probe and then twice at high stringency 
(68C, 0.1 x SSC, 0.1% SDS, 20 min), in a Disk Wisk apparatus (Schleicher and Schuell). 
Blood collection (serum CRP) 
Venous blood (5-7 ml) was collected under a sterile technique in a purple top vaccutainer.  
Blood was processed into serum within 2 hours after collection: the whole blood was kept at 
room temperature for 30-45 minutes to allow a clot to form, and then centrifuged for 12 
minutes to separate the serum from the clot.  Serum was then aliquoted into barcode labeled 
microfuge tubes and quickly frozen at -80°C and stored until analysis using ELISA method. 
Mean serum CRP levels (mg/ml) were compared in diseased and non-diseased groups. 
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Statistical analyses  
Salivary cytokine levels were not normally distributed and between group comparisons were 
made using the non-parametric, non-paired Wilcoxon test. Associations between salivary C. 
albicans CFU/ml and cytokine levels were compared by one-way ANOVA and regression 
analyses. The association between the presence or absence of C. albicans and the presence 
(pooling Type II and Type III) or absence of DS was determined by Chi Square test. A p 
value <0.05 was considered significant, however no adjustments were made for multiple 
comparisons and the results should be interpreted with caution.  
Results 
Salivary Markers comparing Control and Denture Stomatitis 
We measured salivary levels of IL-1α, IL-1ᵦ, IL-6, IL-8 and TNFα.  The data from the DS 
and control subjects appear in Table 2-1.There was a statistically significant increase in 
salivary levels of IL-8 (p=0.04) and IL-1ᵦ (p=0.04) in DS as compared to health.  In DS the 
apparent increase in salivary levels of IL-6, TNFα and IL-1ᵦ were not statistically significant. 
These increases in protein expression were consistent with the increased tissue mRNA 
expression (data not shown). 
A statistically significant association between salivary counts of C. albicans and salivary 
levels of IL-8 (r
2
=0.16, P=0.03), and IL-1α (r2=0.20, P=0.01) was seen as illustrated in 
Figure 2-2.  
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Figure 2-3 shows that C. albicans was detected in saliva of 80% (12/15) of the DS subjects, 
and in 35.3% (6/17) of the Healthy subjects, (p=0.03), using the positive cut-off value of 
(CFU/ml > 400).  
Table 2-1. Salivary Cytokines levels in control and DS groups 
Cytokine Control group  
Median (IQR) [ng/mL] 
DS group  
Median (IQR) 
[ng/mL] 
Wilcoxon 
P value  
IL-1α 342 (202-752) 508 (140-1170) 0.47 
IL-1ᵦ 146 (77-328) 293 (119-1100) 0.04 
IL-6 4.2 (0.0-12.6) 5.2 (0.0-8.4) 0.50 
IL-8 446 (198-847) 792 (447-1970) 0.04 
TNFα 0.0 (0.0-6.2) 5.8 (0.0-14.2) 0.12 
Numbers in bold show statistically significant differences  
Figure 2-2: Scatter plots showing the relationship between C.albicans counts in saliva and 
salivary levels of both A) IL-8, and B) IL-1α. 
 
 
 
40 
 
Figure 2-3. A bar graph showing the C.albicans prevalence in saliva of DS and control 
subjects. 
 
 
Bacterial Composition of Mucosal and Denture surface biofilm determined by DNA-
DNA Checkerboard 
Tissue and denture surfaces were sampled using a plastic curette to measure the presence, 
absence and levels of 16 dental biofilm organisms by DNA-DNA checkerboard. Biofilm 
samples from the palatal tissue surfaces did not show any detectible organisms, suggesting a 
level below 10
4
 counts. Organisms were detected in the biofilm samples collected from 
dentures with (3/17) control subjects, (1/ 8) DS Type II, and (1/7) DS Type III. The data for 
the 3 healthy are compared to the 2 DS in Table 2-2. There were no significant differences in 
the counts comparing Health to Diseased samples. 
 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
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DS (type II 
and III)
C.albicans absent
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* P=0.03
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Table 2-2. Organisms detected with DNA-DNA checkerboard of biofilm from denture 
surfaces. Numbers reflect counts x 10
6
 CFU 
Microorganism Control (Mean ±SD) DS  (Mean±SD) P value 
P. gingivalis  0.8±1.6 0.9±2.2 0.93 
P. intermedia  0.8±1.6 2. 2±4.9 0.42 
P. nigrescens  1.8±3.9 2.4±6.0 0.80 
B. forsythia  3.4±6.5 3.3±7.4 0.97 
T. denticola  2.0±4.0 2.4±5.1 0.84 
A. a  2.5±5.0 3.7±7.9 0.64 
C. rectus  5.3±10.2 9.1±21.9 0.62 
E. corrodens  1.8±3.5 2.2±5.00 0.82 
F. nucleatum  15.1±29.1 17.9±38.3 0.85 
S. noxa  2.5±5.0 4.0±9.4 0.65 
C. ochracea  0.8±1.6 1.4±3.2 0.61 
V. parvula  1.3±3.1 1.9±4.9 0.76 
S. sanguis  2.2±4.3 2.5±5.4 0.86 
S. intermedius  3.1±6.6 3.1±6.5 0.98 
S. Oralis  1.6±3.1 3.0±6.4 0.53 
A. viscosus  6.3±12.6 8.3±17.8 0.75 
 
Serum CRP 
There was no significant difference in the serum CRP level comparing health to DS 
individuals (p=0.74). We also examined levels of clinically elevated CRP values (CRP<3 
mg/ml) as a threshold and again found no difference. Table 2-3. 
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Table 2-3. CRP levels in control and DS groups 
Serum CRP (µg/ml) 
Groups Mean ± SD P value 
Control (n=17) 4980.1 ± 2601.1  
0.74 DS (n=15) 4687.7 ± 2271.8 
 
Discussion 
Cytokines 
Increased levels of GM-CSF, IFN-γ, TNF-α IL-8, IL-18 and IL-1α, IL-1ᵦ, IL-6, have been 
identified in the oral mucosa epithelial cell infection models and saliva of subjects with oral 
candidiasis and in experimental models of oral candidiasis (C. C. Villar, et al. ,2008, A. 
Dongari-Bagtzoglou, et al. ,2005, A. Dongari-Bagtzoglou, et al. ,2003)   
We investigated levels of IL-1α, IL-1ᵦ, IL-6, IL-8, and TNFα in saliva and found a 
statistically significant two fold increase in median salivary levels of IL-8 (p=0.04) and a 1.8-
fold increase in IL-1ᵦ. The increase in the chemokine IL-8 is consistent with neutrophilic 
infiltration and IL-1 ᵦ is a ubiquitous mediator of inflammation. These increases are in 
accordance with other studies that looked at these pro-inflammatory cytokines in oral 
epithelial cells infected with C. albicans (C. C. Villar, et al. ,2008, A. Dongari-Bagtzoglou, et 
al. ,2003, Y. Mostefaoui, et al. ,2004). A study that utilized epithelial cell lines (SCC4, 
SCC15, and OKF6/TERT-2), showed that all cell lines and primary cultures responded to 
C.albicans with an increase in IL-8 secretion. IL-8 responses were contact-dependent, strain-
specific, required yeast viability and germination into hyphae, and were in part, autoregulated  
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by IL-1α (A. Dongari-Bagtzoglou, et al. ,2003). In an in vitro study on engineered human 
oral mucosa it was shown that IL-1ᵦ mRNA expression significantly increased during the 
early stages of infection and decreased during later stages (Y. Mostefaoui, et al. ,2004)  
TNF-α is known to induce secondary production of other cytokines, such as IFN-γ, IL-1, IL-
6, and IL-12 (A. D. Kennedy, et al. ,2007) which further amplifies the protective immune 
response to C.albicans infection (C. C. Villar, et al. ,2008). Reduced levels of C.albicans 
were found on the tongues of infected mice treated by oral administration of TNF-α during 
oral candidiasis consistent with the protective activity of TNFa which is a potent activator of 
monocyte-mediated microbial killing. Several studies have also provided a link between 
lower levels of TNF-α in the oral tissues or saliva of humans and animals with oral C. 
albicans infection (C. C. Villar, et al. ,2008). Thus, TNFα may be an important innate marker 
of inflammation that is protective by promoting C. albicans killing.  However, both IL-1ᵦ 
and TNFα are important mediators of bone resorption and may contribute to the alveolar 
ridge resorption often associated with DS. 
 
We found a significant association between the salivary counts of C. albicans and the levels 
of IL-8 and IL-1α (figure 2). This is suggestive of a dose response relationship where the 
increasing level of C. albicans, triggers increases in IL-8. The synthesis of IL-8 likely arises 
from mucosal epithelium secretion which is challenged by the presence of C. albicans. This 
increase in IL-8 would lead to neutrophil recruitment within the inflamed mucosa and 
passage into the saliva via disrupted epithelial integrity. An increase in neutrophils within the 
saliva has previously been reported in mucositis and in DS subjects (A. Dongari-Bagtzoglou, 
et al. ,2005, A. Dongari-Bagtzoglou, et al. ,2003, A. Ali, et al. ,2006). IL-8 is a potent 
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chemokine for neutrophils at nanomolar concentrations and the level in saliva ranged from 
447-1970 ng/ml. Neutrophils role as a part of innate immunity also includes contribution 
towards initiation of cell-mediated immunity, and the importance of cell-mediated immunity 
against candidal infections through T-cells is well illustrated in AIDS patients that are prone 
to severe mucosal candidal infections. 
 C. albicans was detected in saliva of 80% (12/15) of the DS subjects, but only 41.2% (7/17) 
of the Healthy subjects, (p=0.03). Thus, C. albicans was twice as likely to be present in 
saliva if mild or severe DS was present. Although the presence of C. albicans was strongly 
associated with the presence of DS, numerically there was no clear trend for the salivary 
CFU of C. albicans relating to the clinical severity of DS. 
Microbiology 
It is well understood that adequate attachment of candidal organisms to denture surface is a 
crucial step in the pathogenesis of denture stomatitis. The formation of biofilms on the 
surface of the denture protects these organisms from detachment and removal by salivary 
flow and physical forces (G. Ramage, et al. ,2004, G. Ramage, et al. ,2001). It‟s also worth 
noticing that quorum sensing (QS) occurs both in single species bacterial communities and in 
complex mixed bacterial-yeast communities (J. R. Blankenship, et al. ,2006, T. Pereira-
Cenci, et al. ,2008). However, the role played by saliva or serum pellicles during the 
colonization process and subsequent multilayer biofilm formation is poorly understood (H. 
Nikawa, et al. ,2000, T. Pereira-Cenci, et al. ,2008, H. Nikawa, et al. ,2006, H. Nikawa, et al. 
,2005). Several investigators reported that saliva coating reduces the adherence of C. 
albicans in acrylic resin based materials (T. Pereira-Cenci, et al. ,2008, T. Pereira-Cenci, et 
al. ,2007, L. P. Samaranayake, et al. ,1980). On the other hand, other studies showed 
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increased adherence rates with saliva coating {{1427 Edgerton,M. 1992; 1509 Edgerton,M. 
1993; 1453 Nikawa,H. 2000; 1510 Nikawa,H. 1993; (T. Pereira-Cenci, et al. ,2008) and  
other research groups  found no effect at all of a(H. Nikawa, et al. ,2000, M. Edgerton, et al. 
,1992, M. Edgerton, et al. ,1993, H. Nikawa, et al. ,1993)(H. Nikawa, et al. ,2000, M. 
Edgerton, et al. ,1992, M. Edgerton, et al. ,1993, H. Nikawa, et al. ,1993) saliva coating (H. 
Nikawa, et al. ,1992)(T. Pereira-Cenci, et al. ,2008, Y. Jin, et al. ,2004). 
In this study, tissue and denture surfaces were sampled to measure the presence, absence and 
levels of 16 dental biofilm organisms by DNA-DNA checkerboard. Biofilm samples from the 
palatal tissue surfaces did not show any detectible organism suggesting a level below 10
4
 
counts. Thus, the test organisms were likely below our detection limit. On the other hand, 
organisms were detected in the biofilm samples collected from dentures in 3 control, 1 DS 
Type 2, and 1- DS Type 3. There were no significant differences in the counts comparing 
Health to Diseased samples. However, since all of the mucosal samples were negative as well 
as the majority of the denture samples, it appears that the DNA-DNA checkerboard which 
has a lower detection limit of 10
4
 CFU, lacks adequate sensitivity for further analyses. This 
would suggest that in future studies different approaches can be utilized – such as cultivable, 
HOMIM (Human Oral Microbe Identification Microarray ) or nested PCR (B. Riep, et al. 
,2009, V. Lazarevic, et al. ,2010, M. R. Milward, et al. ,2007, S. S. Kirakodu, et al. ,2008, S. 
C. Gomes, et al. ,2008, R. C. Casarin, et al. ,2010, A. P. Colombo, et al. ,2009). Previous 
cultivable studies of denture surfaces have shown qualitative and/or quantitative differences 
between the microorganisms found on the surfaces and depths of the maxillary denture as 
compared to the respective surfaces and depths of the mandibular denture from different 
patients and between different geographical regions as well as within the same subject (R. T. 
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Glass, et al. ,1990, R. T. Glass, et al. ,2010). According to these studies by Glass et al. they 
found a wide array of oral and systemic disease-producing aerobic and anaerobic 
microorganisms including gram positive and negative cocci and rods and yeasts from the 
cultures that were taken from denture surfaces.  
Sachdeo et al.(A. Sachdeo, et al. ,2008) have used a similar methodology to the one 
performed in our study to characterize the microbiota of edentulous oral cavities using 
checkerboard DNA-DNA hybridization, analyzing samples from mucosal and denture 
surfaces, and saliva from edentulous patients for 41 bacterial species where they found that 
A. actinomycetemcomitans and P. gingivalis, which were thought to be eliminated with the 
extraction of all natural teeth, were seen in significant numbers in the edentulous subjects. 
These organisms were detected in our study as well. Also, when they compared the mean 
total DNA probe counts among the dorsal surfaces of the tongue, denture palates, and the 
subjects‟ palates, the highest mean counts were found on the tongue dorsum, followed by the 
polished (exterior) surface of the denture palate, and were lowest on the hard palate. This 
finding is also consistent with our study where no organisms were detected from the mucosal 
samples. However, no samples were taken from the polished surfaces of the denture in our 
case, as we sampled the tissue-bearing surface. 
Other studies (E. Theilade, et al. ,1988, E. Theilade, et al. ,1983), have shown that the 
predominant cultivable flora of denture plaque was Gram-positive cocci (Streptococci) and 
rod-shaped bacteria (D. R. Radford, et al. ,1999). Results from such studies suggest similarity 
between denture plaque bacterial composition and the periodontal niche in dentate patients. 
Therefore, consistent with the association of periodontal disease and specific periodontal 
pathogens on conditions such as cardiovascular disease and poor glycemic control among 
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diatbetics it has been suggested that denture cleaning is important to oral and systemic health 
and that the denture-wearing population requires care and follow-up similar to their non-
denture-wearing counterparts (A. Sachdeo, et al. ,2008). 
 
C-reactive Protein in Denture Stomatitis 
We found no significant difference in levels of CRP between the two groups of patients. 
Same observation was found by Kostial el. al.(I. Kostiala. ,1984) where CRP values in 
patients with acute fungal stomatitis in non-immunocompromised patients were within 
normal ranges
 
(I. Kostiala. ,1984)
. 
On the other hand, Ajwani et al. found that edentulous 
individuals with signs of oral candidosis or denture stomatitis showed elevated levels of 
serum CRP and salivary microbial counts (S. Ajwani, et al. ,2003). It has been reported that 
CRP levels are higher in patients with periodontitis (J. D. Beck, et al. ,2002, R. G. Craig, et 
al. ,2003, F. D'Aiuto, et al. ,2005, J. L. Ebersole, et al. ,2002, T. N. Salzberg, et al. ,2006, G. 
D. Slade, et al. ,2000), and in our study and elsewhere in the literature it has been 
demonstrated that there is similarity between the microbial content of denture plaque and that 
associated with periodontitis. However, CRP levels association with edentulism and the clues 
it may provide for DS diagnosis is still not understood.  In addition, CRP is only marker of 
the hepatic acute phase response. It is possible that fungal infections, which activate a 
different microbial pathogen recognition system than bacteria, may specifically trigger the 
release of different hepatic acute phase reactants, such as alpha anti-trypsin, transferrin or 
orosomucoid synthesis. 
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Conclusions 
Elevated levels of salivary IL-8 and IL-1ᵦ are associated with DS, and IL-8 is positively 
associated with increased levels of C. albicans in saliva. This finding suggests that topical 
therapeutics to reduce these inflammatory and infectious agents may be logical therapeutic 
strategies. Denture plaque has similar composition to periodontitis associated microbiota 
where C. albicans acts as an early colonizer facilitating the attachment of anaerobic 
microorganisms. At this point the data do not support the concept that DS induces systemic 
inflammation as measured by CRP levels.  
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Conclusions 
 
In this report we confirm the association of Candidal overgrowth and identify the denture as 
the primary infectious reservoir. Data suggests that denture plaque has similar composition to 
periodontitis associated microbiota which suggests that complete denture wearers should 
probably have regular follow ups similar to their dentate counter parts. Candida-associated 
denture stomatitis, even if asymptomatic, should be treated as it may act as reservoir for 
infections, and could encourage the resorption of the alveolar bone. No significant role was 
found for both hyposalivation and xerostomia symptoms as possible disease modifiers. 
Elevated levels of salivary IL-8 and IL-1ᵦ are associated with DS, and IL-8 is positively 
associated with increased levels of C. albicans in saliva. However, on the systemic level, data 
did not support the concept that DS induces systemic inflammation as measured by CRP 
levels. These findings provide new opportunities for the development of both new diagnostic 
and therapeutic tools to manage candidal infection including the possible utilization of the 
chemokines such as IL-8 in the topical therapeutics field. Finally, the findings from this 
relatively small exploratory study should be interpreted with caution but provide 
observations for future investigation. 
 
 
 
